StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Verbindung

Emedastine

HCID 3219
Neue Reaktion
Drucken

Daten werden ergänzt – lade die Seite später neu, um den aktuellen Stand zu sehen

GrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung
TeilstruktursucheÄhnliche Strukturen suchen

Grundinformationen

CAS
87233-61-2
Standard-SMILES
CCOCCn1c(N2CCCN(C)CC2)nc2ccccc21
InChIKey
KBUZBQVCBVDWKX-UHFFFAOYSA-N
Summenformel
C17H26N4O
Durchschnittliche Molmasse
302,4 g/mol
Monoisotopische Masse
302,21066145

Überblick

Emedastine is 1-Methyl-1,4-diazepane in which the hydrogen attached to the nitrogen at position 4 is substituted by a 1-(2-ethoxyethyl)-1H-benzimidazol-2-yl group. A relatively selective histamine H1 antagonist, it is used as the difumatate salt for allergic rhinitis, urticaria, and pruritic skin disorders, and in eyedrops for the symptomatic relief of allergic conjuntivitis. It has a role as a H1-receptor antagonist, an anti-allergic agent and an antipruritic drug.

Namen und Bezeichner

Bevorzugter Name
Emedastine
IUPAC
1-(2-ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)benzimidazole
Englischer Name
Emedastine
Summenformel
C17H26N4O
Molmasse
302.41

Namen und Synonyme

emedastine87233-61-2EmedastinaEmedastinum1-(2-Ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)benzimidazole9J1H7Y9OJV1-(2-ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)-1H-1,3-benzodiazole1-[2-(ethoxy)ethyl]-2-(4-methyl-1-homopiperazinyl)benzimidazoleCHEBI:4779DTXSID70482431-(2-Ethoxy-ethyl)-2-(4-methyl-[1,4]diazepan-1-yl)-1H-benzoimidazole1H-Benzimidazole, 1-(2-ethoxyethyl)-2-(hexahydro-4-methyl-1H-1,4-diazepin-1-yl)-
Weitere Namen anzeigen
EmestineEmedastine impurity FEmedastinc Impurity CEmedastine Impurity CEmedastine Impurity 14Emedastine, 10 mM in DMSO1-(2-Ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)benzimidazole1-(2-Ethoxyethyl)-2-(4-methyl-1,4-diazepan-1-yl)-1H-benzimidazole
KG 24131-(2-(ethoxy)ethyl)-2-(4-methyl-1-homopiperazinyl)benzimidazole1-(2-Ethoxy-ethyl)-2-(4-methyl-(1,4)diazepan-1-yl)-1H-benzoimidazoleRefChem:590745DTXCID8028218S01GX06Emedastine [INN]Emedastinum [INN-Latin]

Eigenschaften

Berechnete StruktureigenschaftenWird ergänzt

XLogP
2,2
Polarare Oberfläche (TPSA)
33,5 Ų
H-Brücken-Donoren
0
H-Brücken-Akzeptoren
4
Frei drehbare Bindungen
5
Schwere Atome
22
Formalladung
0
Komplexität
341

Experimentelle und physikochemische Eigenschaften

DrugsPharmaceuticals -> Listed in ZINC15
LogP2.6
Solubility · 2 Einträge

Soluble (difumarate formulation)

1.44e+00 g/L

Human Drugs · 2 Einträge

Breast Feeding; Lactation; Milk, Human; Antihistamines

EMA approved medicines: Human medicine

Physical DescriptionSolid

Physikochemische Eigenschaften

Siedepunkt
446.6 · 446.6±55.0 °C(Predicted)
Dichte
1.15 · 1.15±0.1 g/cm3(Predicted)
storage temp.
2 · 2-8°C
Löslichkeit
125 mg/mL · DMSO: 125 mg/mL (413.35 mM); Ethanol: 100 mg/mL (330.68 mM)
pka
8.86 · 8.86±0.10(Predicted)

Sicherheit und Regulatorisches

Sicherheitsangaben dienen nur zur Orientierung und ersetzen weder das Sicherheitsdatenblatt (SDB) des Lieferanten noch geltende Vorschriften oder eine fachliche Bewertung.

Toxikologische Informationen

Effects During Pregnancy and Lactation◉ Summary of Use during Lactation

Chemie und Industrie

Pharmakologische Informationen

ATC Code · 3 Einträge

S01GX06

S - Sensory organs

QS - Sensory organs

PharmacodynamicsEmedastine is a relatively selective H<sub>1</sub>-receptor antagonist.
Mechanism of Action · 1 Eintrag

Emedastine is a relatively selective, histamine H<sub>1</sub> antagonist. In vitro examinations of emedastine's affinity for histamine receptors demonstrate relative selectivity for the H<sub>1</sub> histamine receptor. In vivo studies have shown concentration-dependent inhibition of histamine-stimulated vascular permeability in the conjunctiva following topical ocular administration. Emedastine appears exert negligible effects on adrenergic, dopaminergic and serotonin receptors.

Biological Half-LifeThe elimination half-life in the plasma is 3-4 hours following oral administration.
Metabolism/MetabolitesTwo primary metabolites, 5-hydroxyemedastine and 6-hydroxyemedastine, are excreted in the urine as both free and conjugated forms. Minor metabolites include the 5'-oxoanalogs of 5-hydroxyemedastine and 6-hydroxy-emedastine and the N-oxide.
FDA Pharmacological Classification · 5 Einträge

9J1H7Y9OJV

EMEDASTINE

Mechanisms of Action [MoA] - Histamine H1 Receptor Antagonists

Established Pharmacologic Class [EPC] - Histamine-1 Receptor Inhibitor

Emedastine is a Histamine-1 Receptor Inhibitor. The mechanism of action of emedastine is as a Histamine H1 Receptor Antagonist.

MeSH Pharmacological Classification · 2 Einträge

Drugs that selectively bind to but do not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine. Included here are the classical antihistaminics that antagonize or prevent the action of histamine mainly in immediate hypersensitivity. They act in the bronchi, capillaries, and some other smooth muscles, and are used to prevent or allay motion sickness, seasonal rhinitis, and allergic dermatitis and to induce somnolence. The effects of blocking central nervous system H1 receptors are not as well understood.

Zugehörige Reaktionen

10
Reaktionsaufzeichnung erstellen
Reaktionsgleichung von HRID 149394
HRID 149394als Edukt
Reaktionsgleichung von HRID 197660
HRID 197660als Produkt
Reaktionsgleichung von HRID 637016
HRID 637016als Produkt
Reaktionsgleichung von HRID 637017
HRID 637017als Edukt
Reaktionsgleichung von HRID 1388162
HRID 1388162als Produkt
Reaktionsgleichung von HRID 1546942
HRID 1546942als Produktals Edukt
Reaktionsgleichung von HRID 1584426
HRID 1584426als Produkt
Reaktionsgleichung von HRID 1584427
HRID 1584427als Edukt
ZurückSeite 1 von 2

Notizen zur Verbindung

Auf dieser SeiteGrundinformationenÜberblickNamen und BezeichnerEigenschaftenSicherheit und RegulatorischesChemie und IndustrieZugehörige ReaktionenNotizen zur Verbindung

Datenbank-Bezeichner

CAS
87233-61-2
PubChem CID
3219
DTXSID
DTXSID7048243
ChEMBL
CHEMBL594
ChEBI
CHEBI:4779
UNII
9J1H7Y9OJV
Nikkaji
J253.163A
Aggregatzustand
Viscous Liquid
Farbe
Yellow to brown
CAS Datenbank
87233 · 87233-61-2(CAS DataBase Reference)

Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475)

Absorption, Distribution and Excretion · 2 Einträge

Ophthalmic use of emedastine usually does not produce measurable plasma concentrations.

Following oral administration, approximately 44% of the total dose can be recovered in the urine over the 24-hour period, with only 3.6% of the dose excreted as unchanged form. Two primary metabolites, 5- and 6-hydroxyemedastine, are excreted in the urine as both free and conjugated forms.

Cellular LocationsMembrane
Metabolite PathwaysEmedastine H1-Antihistamine Action

Anwendungen

VerwendenAntihistaminic, H1-receptor; asthma prophylactic; anti-allergic.

Vor- und nachgelagerte Produkte

Vorgelagerte Rohstoffe

N-(2-Ethoxy-ethyl)-benzene-1,2-diamine(2-Ethoxy-ethyl)-(2-nitro-phenyl)-amineEMEDASTINE IMPURITY E1-(2-Ethoxy-ethyl)-1,3-dihydro-benzoimidazol-2-one1H-Benzimidazole,2-chloro-1-(2-ethoxyethyl)1-Boc-hexahydro-1,4-diazepineN-Methylhomopiperazine2-Chlor-1H-benzimidazolAnilinFormaldehyd1-Chlor-2-nitrobenzol
Ergänzende Hinweise · 1 Eintrag

DefinitionChEBI: 1-Methyl-1,4-diazepane in which the hydrogen attached to the nitrogen at position 4 is substituted by a 1-(2-ethoxyethyl)-1H-benzimidazol-2-yl group. A relatively selective histamine H1 antagonist, it is used as the ifumatate salt for allergic rhinitis, urticaria, and pruritic skin disorders, and in eyedrops for the symptomatic relief of allergic conjuntivitis.